More cancer patients in England are getting approved drugsBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7570.671 (Published 28 September 2006) Cite this as: BMJ 2006;333:671
- Susan Mayor
The percentage of patients with cancer in England who are being treated with drugs approved for use in the NHS is growing, says a report published this week. And although regional variations in access to drugs remain, these are falling.
The report, from Mike Richards, England's national cancer director, showed an average increase of 47% in the use of cancer drugs approved by the National Institute for Health and Clinical Excellence (NICE), the body that regulates drug use by the NHS, during the first six months of 2005, in comparison with a previous review that was based …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial